Direct taxes
Manual | Page | Comments |
---|---|---|
Corporate Intangibles Research And Development Manual | New: CIRD110000-CIRD192000 | As noted above new content has been published to provide guidance on the Finance Act 2024 amendments to the R&D regime including guidance on: • the new merged scheme (new RDEC) (CIRD110000) • the enhanced R&D intensive support (ERIS) (CIRD120000) • categories of qualifying expenditure (CIRD130000) • PAYE cap (CIRD140000) • overseas restrictions (CIRD150000) • contracted out R&D (CIRD160000) • the new claims process (CIRD180000) • exempt foreign PEs (CIRD190000) • going concerns (CIRD191000) and • connected persons (CIRD192000). |
Updated: CIRD81920 | New wording provided for pharmaceutical entities to clarify whether the four basic stages (drug discovery preclinical... |
If you or your firm subscribes to Taxjournal.com, please click the login box below:
If you do not subscribe but are a registered user, please enter your details in the following boxes:
Direct taxes
Manual | Page | Comments |
---|---|---|
Corporate Intangibles Research And Development Manual | New: CIRD110000-CIRD192000 | As noted above new content has been published to provide guidance on the Finance Act 2024 amendments to the R&D regime including guidance on: • the new merged scheme (new RDEC) (CIRD110000) • the enhanced R&D intensive support (ERIS) (CIRD120000) • categories of qualifying expenditure (CIRD130000) • PAYE cap (CIRD140000) • overseas restrictions (CIRD150000) • contracted out R&D (CIRD160000) • the new claims process (CIRD180000) • exempt foreign PEs (CIRD190000) • going concerns (CIRD191000) and • connected persons (CIRD192000). |
Updated: CIRD81920 | New wording provided for pharmaceutical entities to clarify whether the four basic stages (drug discovery preclinical... |
If you or your firm subscribes to Taxjournal.com, please click the login box below:
If you do not subscribe but are a registered user, please enter your details in the following boxes: